Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 1100

1.

New strategies for the optimal use of platelet transfusions.

Blajchman MA, Slichter SJ, Heddle NM, Murphy MF.

Hematology Am Soc Hematol Educ Program. 2008:198-204. doi: 10.1182/asheducation-2008.1.198.

PMID:
19074082
2.

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.

Estcourt L, Stanworth S, Doree C, Hopewell S, Murphy MF, Tinmouth A, Heddle N.

Cochrane Database Syst Rev. 2012 May 16;5:CD004269. doi: 10.1002/14651858.CD004269.pub3. Review.

PMID:
22592695
3.

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Crighton GL, Estcourt LJ, Wood EM, Trivella M, Doree C, Stanworth S.

Cochrane Database Syst Rev. 2015 Sep 30;9:CD010981. doi: 10.1002/14651858.CD010981.pub2. Review.

4.

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.

Stanworth SJ, Hyde C, Heddle N, Rebulla P, Brunskill S, Murphy MF.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004269. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD004269.

PMID:
15495093
5.

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P, Murphy MF.

Cochrane Database Syst Rev. 2015 Oct 27;10:CD010984. doi: 10.1002/14651858.CD010984.pub2. Review.

6.

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF.

Cochrane Database Syst Rev. 2015 Nov 18;11:CD010983. doi: 10.1002/14651858.CD010983.pub2. Review.

7.

Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats.

Abrams-Ogg AC.

Vet Clin North Am Small Anim Pract. 2003 Nov;33(6):1401-18. Review.

PMID:
14664205
8.

Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.

Apelseth TO, Hervig T, Bruserud O.

Blood Rev. 2011 May;25(3):113-22. doi: 10.1016/j.blre.2011.01.006. Epub 2011 Feb 12. Review.

PMID:
21316823
10.

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia.

Heddle NM, Cook RJ, Tinmouth A, Kouroukis CT, Hervig T, Klapper E, Brandwein JM, Szczepiorkowski ZM, AuBuchon JP, Barty RL, Lee KA; SToP Study Investigators of the BEST Collaborative.

Blood. 2009 Feb 12;113(7):1564-73. doi: 10.1182/blood-2008-09-178236. Epub 2008 Dec 24.

11.

Prophylactic platelet transfusions: which dose is the best dose? A review of the literature.

Tinmouth AT, Freedman J.

Transfus Med Rev. 2003 Jul;17(3):181-93. Review.

PMID:
12881779
13.

Platelet dose for prophylactic platelet transfusions.

Cid J, Lozano M.

Expert Rev Hematol. 2010 Aug;3(4):397-400. doi: 10.1586/ehm.10.36.

PMID:
21083030
14.

A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger.

Zumberg MS, del Rosario ML, Nejame CF, Pollock BH, Garzarella L, Kao KJ, Lottenberg R, Wingard JR.

Biol Blood Marrow Transplant. 2002;8(10):569-76.

PMID:
12434952
15.

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H.

Blood. 1998 May 15;91(10):3601-6.

16.

Optimizing platelet transfusion therapy.

Heal JM, Blumberg N.

Blood Rev. 2004 Sep;18(3):149-65. Review.

PMID:
15183900
17.

A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.

Messerschmidt GL, Makuch R, Appelbaum F, Ungerleider RS, Abrams R, O'Donnell J, Holohan TV, Fontana J, Wright D, Anagnou NP, et al.

Cancer. 1988 Aug 15;62(4):795-801.

18.

Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?

Stanworth SJ, Hyde C, Brunskill S, Murphy MF.

Br J Haematol. 2005 Dec;131(5):588-95. Review.

PMID:
16351634
19.

Pretransfusion trigger platelet counts and dose for prophylactic platelet transfusions.

Strauss RG.

Curr Opin Hematol. 2005 Nov;12(6):499-502. Review.

PMID:
16217169
20.

Relationship between platelet count and bleeding risk in thrombocytopenic patients.

Slichter SJ.

Transfus Med Rev. 2004 Jul;18(3):153-67. Review.

PMID:
15248165
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk